Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
#918483
ClinicalTrials.gov
Panobinostat/Velcade in Multiple Myeloma
#889902
ClinicalTrials.gov
Serum NGAL IN Patients With Multiple Myeloma
#903809
ClinicalTrials.gov
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
#873106
ClinicalTrials.gov
68Ga-BCMA PET/CT in Multiple Myeloma
#991969
ClinicalTrials.gov
Trial of Romidepsin and Bortezomib for Multiple Myeloma
#848663
ClinicalTrials.gov
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
#806581
ClinicalTrials.gov
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
#895588
ClinicalTrials.gov
Vaccine Therapy in Treating Patients With Multiple Myeloma
#314388
ClinicalTrials.gov
Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma
#806306
ClinicalTrials.gov
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
#835188
ClinicalTrials.gov
Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
#865154
ClinicalTrials.gov
Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple
#886948
ClinicalTrials.gov
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
#888600
ClinicalTrials.gov
Tinostamustine Conditioning and Autologous Stem Cell
#917565
ClinicalTrials.gov
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
#424194
ClinicalTrials.gov
Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma
#148750
ClinicalTrials.gov
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
#840976
ClinicalTrials.gov
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
#882181
ClinicalTrials.gov
Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
#849646
ClinicalTrials.gov
Oral ONC201 in Relapsed/Refractory Multiple Myeloma
#807502
ClinicalTrials.gov
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
#871623
ClinicalTrials.gov
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
#871854
ClinicalTrials.gov
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
#201786
ClinicalTrials.gov
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
#843652
ClinicalTrials.gov
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
#898751
ClinicalTrials.gov
Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
#898250
ClinicalTrials.gov
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
#876937
ClinicalTrials.gov
Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
#857969
ClinicalTrials.gov
Phase I/II Study of hLL1 in Multiple Myeloma
#917568
ClinicalTrials.gov
A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors
#875665
ClinicalTrials.gov
Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma
#888754
ClinicalTrials.gov
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
#871678
ClinicalTrials.gov
Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
#843673
ClinicalTrials.gov
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
#875214
ClinicalTrials.gov
agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma
#444881
ClinicalTrials.gov
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
#844247
ClinicalTrials.gov
Connect® MM- The Multiple Myeloma Disease Registry
#880358
ClinicalTrials.gov
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
#907163
ClinicalTrials.gov
Agaricus Blazei Murill in Patients With Multiple Myeloma
#914817
ClinicalTrials.gov
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
#833842
ClinicalTrials.gov
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform
#359889
Gestión del Repositorio Documental de la Universidad de Salamanca
The Indiana Myeloma Registry
#895706
ClinicalTrials.gov
Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma
#829507
ClinicalTrials.gov
Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
#840847
ClinicalTrials.gov
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
#841981
ClinicalTrials.gov
Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma
#849008
ClinicalTrials.gov
Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
#865853
ClinicalTrials.gov
Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients
#918545
ClinicalTrials.gov
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
#803478
ClinicalTrials.gov
← Previous
Page 2 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.